Can a simple mouth device restore speech after tongue cancer?
NCT ID NCT02584270
First seen May 13, 2026 · Last updated Jun 21, 2026 · Updated 6 times
Summary
This study tests whether a custom dental device called a palatal augmentation prosthesis (PAP), along with speech therapy, can improve how well people speak and swallow after surgery for small tongue cancers (T1/T2). Forty participants will be randomly assigned to receive the device plus therapy or standard care. The main goal is to see if words are easier to understand six months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TONGUE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Palatal Augmentation Prosthesis (PAP) and articulation therapy
What this could lead to
If it works, this could provide a standard way to help people with small tongue cancers speak and swallow better after surgery.
What could go wrong
This is a small, early-stage trial with only 40 people, so results may not apply to everyone. The device requires regular wear and therapy, which may not suit all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.